A dual altered peptide ligand down-regulates myasthenogenic T cell responses and reverses experimental autoimmune myasthenia gravis via up-regulation of Fas–FasL-mediated apoptosis

Ähnliche Einträge

• A 50-kDa ERK-like protein is up-regulated by a dual altered peptide ligand that suppresses myasthenia gravis-associated responses
  von: Ben-David, Hava, et al.
  Veröffentlicht: (2006)
• Oral administration of a dual analog of two myasthenogenic T cell epitopes down-regulates experimental autoimmune myasthenia gravis in mice
  von: Paas-Rozner, Miri, et al.
  Veröffentlicht: (2000)
• Suppression of myasthenogenic responses of a T cell line by a dual altered peptide ligand by induction of CD4(+)CD25(+) regulatory cells
  von: Aruna, Badiga Venkata, et al.
  Veröffentlicht: (2005)
• Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4(+)CD25(+)-regulated events leading to apoptosis
  von: Ben-David, Hava, et al.
  Veröffentlicht: (2005)
• A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4(+) T cells
  von: Paas-Rozner, Miri, et al.
  Veröffentlicht: (2003)